igf-1 lr3 vs igf-1 Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer IGF-1 LR3 vs IGF-1 DES:

That means: It is not FDA approved for general human use outside clinical trials

Recombinant human IGF-1 LR3 protein QK041 Brand: Qkine Human insulin-like growth factor 1 long arginine 3 (IGF-1 LR3) protein is a synthetic analog of IGF-1

13-residue N-terminal extension (MFPAMPLSSFVNQ) for extended stability Formula / M.W.: C 400 H 625 N 111 O 115 S 9 , ~9111 g/mol CAS: 946870-92-4 Disclaimer This product is intended for laboratory research use only

Body composition changes such as reduced belly fat and increased muscle definition typically take 612 weeks to become noticeable

Since IGF-1 plays a natural role in cell repair and collagen production, the LR3 version may encourage healthier, more resilient skin

Standard Research Protocol Dose: 300 mcg per day subcutaneous injection Timing: Morning, fasted state (at least 30 minutes before food or exercise for maximal absorption) Cycle length: Typically 8 to 12 weeks on, followed by a 4-week rest period Reconstitution: Standard BAC water reconstitution